Published in Ann Oncol on November 06, 2012
Whole-exome sequencing reveals the mutational spectrum of testicular germ cell tumours. Nat Commun (2015) 1.64
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol (2012) 1.44
Chemotherapy for testicular cancer induces acute alterations in diastolic heart function. Br J Cancer (2013) 1.04
Cardiovascular disease after cancer therapy. EJC Suppl (2014) 0.83
Comment on 'Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors'. Br J Cancer (2013) 0.82
Long-term exposure to circulating platinum is associated with late effects of treatment in testicular cancer survivors. Ann Oncol (2015) 0.81
The genomic landscape of testicular germ cell tumours: from susceptibility to treatment. Nat Rev Urol (2016) 0.81
Vascular Complications of Cancer Chemotherapy. Can J Cardiol (2015) 0.79
Etiology and early pathogenesis of malignant testicular germ cell tumors: towards possibilities for preinvasive diagnosis. Asian J Androl (2015) 0.78
Polygenic susceptibility to testicular cancer: implications for personalised health care. Br J Cancer (2015) 0.78
Rare disruptive mutations in ciliary function genes contribute to testicular cancer susceptibility. Nat Commun (2016) 0.75
Re: Early development of the metabolic syndrome after chemotherapy for testicular cancer. J Urol (2014) 0.75
Cancer and Its Association With the Development of Coronary Artery Calcification: An Assessment From the Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc (2015) 0.75
Dynamics of hormonal disorders following unilateral orchiectomy for a testicular tumor. Med Oncol (2017) 0.75
Vitamin D status among long-term survivors of testicular cancer. Oncotarget (2016) 0.75
At what price do we treat patients with testicular cancer? EJC Suppl (2013) 0.75
Clinical significance of androgen secretion disorders in men with a malignancy. Med Oncol (2017) 0.75
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
[Breast cancer and the use of the hormones around the menopause]. Ned Tijdschr Geneeskd (2003) 3.86
[Assessment of renal function according to the NHG protocol 'Diabetes mellitus type 2': risk of overestimating the number of diabetes patients with renal dysfunction]. Ned Tijdschr Geneeskd (2007) 2.96
Oral contraceptives and risk of breast cancer in women aged 20-54 years. Netherlands Oral Contraceptives and Breast Cancer Study Group. Lancet (1994) 2.95
[Cancer incidence in the Schiphol area in 1988-1993]. Ned Tijdschr Geneeskd (1997) 2.68
Lack of specific renal haemodynamic effects of different doses of dopamine after infrarenal aortic surgery. Br J Anaesth (1996) 2.67
Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. J Med Genet (2005) 2.65
Tubular kidney injury molecule-1 (KIM-1) in human renal disease. J Pathol (2007) 2.63
Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial. J Clin Oncol (1996) 2.61
Preventive intervention possibilities in radiotherapy- and chemotherapy-induced oral mucositis: results of meta-analyses. J Dent Res (2006) 2.56
The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men. Kidney Int (2006) 2.54
ROC analysis of noninvasive tests for peripheral arterial disease. Ultrasound Med Biol (1996) 2.46
Induced abortion and risk for breast cancer: reporting (recall) bias in a Dutch case-control study. J Natl Cancer Inst (1996) 2.36
Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group. J Clin Oncol (1997) 2.29
Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med (2000) 2.19
Severe exacerbations predict excess lung function decline in asthma. Eur Respir J (2007) 2.18
Effects of low-dose dopamine on renal and systemic hemodynamics during incremental norepinephrine infusion in healthy volunteers. Crit Care Med (1998) 2.15
Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence. J Clin Oncol (2000) 2.09
[Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up]. Ned Tijdschr Geneeskd (2008) 2.06
[Genetic research with stored human tissue: a coding procedure with optimal use of information and protection of privacy]. Ned Tijdschr Geneeskd (2004) 2.06
Ambient and biological monitoring of cokeoven workers: determinants of the internal dose of polycyclic aromatic hydrocarbons. Br J Ind Med (1990) 2.06
Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol (2007) 1.98
Inverse relationship between blood glucose and autonomic function in healthy subjects. Diabetes Care (2000) 1.97
Prospective evaluation of early cardiac damage induced by epirubicin-containing adjuvant chemotherapy and locoregional radiotherapy in breast cancer patients. J Clin Oncol (2001) 1.92
Anti-inflammatory effects of inhaled carbon monoxide in patients with COPD: a pilot study. Eur Respir J (2007) 1.90
Childhood factors associated with asthma remission after 30 year follow up. Thorax (2004) 1.90
Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis. Eur J Surg Oncol (1995) 1.90
Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. J Clin Oncol (2000) 1.89
The effect of surgical wounding on tumour development. Eur J Surg Oncol (1999) 1.88
Quality of life in patients with paroxysmal atrial fibrillation and its predictors: importance of the autonomic nervous system. Eur Heart J (2001) 1.87
Chromosomal damage in peripheral blood lymphocytes of patients treated for testicular cancer. Hum Genet (1990) 1.84
Effects of rosuvastatin and atorvastatin on glycaemic control in Type 2 diabetes---the CORALL study. Diabet Med (2012) 1.75
The Corsi Block-Tapping Task: standardization and normative data. Appl Neuropsychol (2000) 1.74
Objectives for an internship internal medicine: from the Dutch Blueprint (Raamplan 1994) to implementation into a practical logbook. Neth J Med (1999) 1.70
Long-term cause-specific mortality among five-year survivors of childhood cancer. Pediatr Blood Cancer (2004) 1.68
Prognostic versus predictive value of biomarkers in oncology. Eur J Cancer (2008) 1.65
Symptom scoring systems to diagnose distal polyneuropathy in diabetes: the Diabetic Neuropathy Symptom score. Diabet Med (2002) 1.65
The association of eosinophilia with lymphoblastic leukaemia or lymphoma: a study of seven patients. Br J Haematol (1980) 1.63
The fibrosis marker galectin-3 and outcome in the general population. J Intern Med (2011) 1.62
Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins. J Clin Oncol (2000) 1.62
The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis. Cancer Treat Rev (2004) 1.60
Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. J Clin Oncol (1995) 1.60
Polymorphisms of the ADAM33 gene are associated with accelerated lung function decline in asthma. Clin Exp Allergy (2004) 1.55
The Dutch Childhood Oncology Group guideline for follow-up of asymptomatic cardiac dysfunction in childhood cancer survivors. Ann Oncol (2012) 1.54
Is sentinel node biopsy beneficial in melanoma patients? A report on 200 patients with cutaneous melanoma. Eur J Surg Oncol (2002) 1.54
Treatment-associated leukemia following testicular cancer. J Natl Cancer Inst (2000) 1.54
p53 protein overexpression in relation to risk factors for breast cancer. Am J Epidemiol (1996) 1.54
[The prevalence of the metabolic syndrome in the Netherlands: increased risk of cardiovascular diseases and diabetes mellitus type 2 in one quarter of persons under 60]. Ned Tijdschr Geneeskd (2007) 1.54
Optimum number of oocytes for a successful first IVF treatment cycle. Reprod Biomed Online (2006) 1.53
Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 1.52
Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract. Eur J Cancer (1980) 1.52
Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study. Ann Oncol (2004) 1.52
Maternal and paternal transmission of type 2 diabetes: influence of diet, lifestyle and adiposity. J Intern Med (2011) 1.50
Malignant struma ovarii treated by ovariectomy, thyroidectomy, and 131I administration. Cancer (1987) 1.50
Pesticides and other occupational exposures are associated with airway obstruction: the LifeLines cohort study. Occup Environ Med (2013) 1.50
Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor. Ann Oncol (2012) 1.50
Continuous leakage measurement during hyperthermic isolated limb perfusion. Ann Surg Oncol (2001) 1.49
Time course of specific AGEs during optimised glycaemic control in type 2 diabetes. Neth J Med (2006) 1.46
Reference values of skin autofluorescence. Diabetes Technol Ther (2010) 1.44
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol (2012) 1.44
Comparison of cytogenetic abnormalities and deoxyribonucleic acid ploidy of benign, borderline malignant, and different grades of malignant soft tissue tumors. Lab Invest (1994) 1.44
Increased risk of fundic gland polyps during long-term proton pump inhibitor therapy. Aliment Pharmacol Ther (2006) 1.44
Syndrome X in testicular-cancer survivors. Lancet (2001) 1.43
Excessively high cell proliferation in sigmoid colon after an oral purge with anthraquinone glycosides. J Natl Cancer Inst (1995) 1.43
ATM-heterozygous germline mutations contribute to breast cancer-susceptibility. Am J Hum Genet (2000) 1.42
Imaging of soft-tissue tumors using L-3-[iodine-123]iodo-alpha-methyl-tyrosine single photon emission computed tomography: comparison with proliferative and mitotic activity, cellularity, and vascularity. Clin Cancer Res (2000) 1.42
[Sensible family planning: pitfalls and dilemmas]. Ned Tijdschr Geneeskd (2008) 1.42
Interference from heterophilic antibodies in seven current TSH assays. Ann Clin Biochem (2008) 1.42
Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review. Eur J Surg Oncol (2003) 1.41
Predicting postoperative mortality after colorectal surgery: a novel clinical model. Colorectal Dis (2014) 1.41
[Diagnostics and treatment of cholangiocarcinoma]. Ned Tijdschr Geneeskd (2008) 1.41
5-Fluorouracil/leucovorin/interferon alpha-2a in patients with advanced colorectal cancer. Effects of maintenance therapy on remission duration. Cancer (1995) 1.40
[Myositis as the first manifestation of an exacerbation of Crohn's disease]. Ned Tijdschr Geneeskd (2007) 1.39
[Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients]. Ned Tijdschr Geneeskd (2005) 1.39
[Passive smoking and lung cancer: a new report in perspective]. Ned Tijdschr Geneeskd (1997) 1.39
The challenge of multidisciplinary research: improving diabetic pregnancy together. Neth J Med (2013) 1.39
Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero. Blood (1999) 1.39
Groin dissection in the treatment of lower-extremity melanoma. Short-term and long-term morbidity. Arch Surg (1992) 1.38
[Two patients with mitochondrial respiratory chain disease]. Ned Tijdschr Geneeskd (2008) 1.38
Physical activity and breast cancer risk in women aged 20-54 years. J Natl Cancer Inst (2000) 1.38
Bacteriological aspects of selective decontamination of the digestive tract as a method of infection prevention in granulocytopenic patients. Antimicrob Agents Chemother (1981) 1.37
The clinical trail of TRAIL. Eur J Cancer (2006) 1.35
The current status of S-100B as a biomarker in melanoma. Eur J Surg Oncol (2012) 1.34
Cutaneous reactions to captopril. Predictive value of skin tests. Clin Allergy (1984) 1.34
Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma. Eur J Surg Oncol (2006) 1.33
Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus. Diabetologia (2009) 1.32
Acute effects of urban air pollution on respiratory health of children with and without chronic respiratory symptoms. Occup Environ Med (1999) 1.32
Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer. Ann Surg Oncol (2004) 1.31